ロード中...

Thalidomide increases both intra-tumoural tumour necrosis factor-α production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid

5,6-Dimethylxanthenone-4-acetic acid (DMXAA), synthesized in this laboratory and currently in phase I clinical trial, is a low molecular weight inducer of tumour necrosis factor-α (TNF-α). Administration of DMXAA to mice with established transplantable tumours elicits rapid vascular collapse selecti...

詳細記述

保存先:
書誌詳細
主要な著者: Cao, Z, Joseph, W R, Browne, W L, Mountjoy, K G, Palmer, B D, Baguley, B C, Ching, L-M
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 1999
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2362281/
https://ncbi.nlm.nih.gov/pubmed/10360649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690415
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!